SciClone Message Board - Msg: 3371285

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SciClone

SCLN 11.15

0.0%

Oct 20 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: glenn blettner who wrote (83)	2/8/1998 1:02:00 AM
From: Jasman	Read Replies (1) of 93

My father passed away because of Hep B. I haven't seen the clinical data of SciClone's lead drug but if it helps those suffering from terminal Hep B, God help SciClone. Actually, Hep B is not very common in the states but in Asia, watch out! Hepatitis B actually leads into liver disease, which is the hardening of the liver. From what the doctors told my family, less than 25% of Hep B carriers actually develop liver disease or anything life threatening. This may be the reason why an absolute cure seems unlikely. The virus just adapts to its environment and rarely kills the host. Just wanted to share what I know about Hepatitis B. By the way, everyone should get immunized from Hep B. There are vaccines for Hepatitis B at every hospital. It costs about $160 for a total of 6 shots.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next